| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AMG-706 | GDSC1000 | pan-cancer | AAC | 0.17 | 0.0003 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0003 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0004 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | -0.16 | 0.0004 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0004 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0004 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | -0.15 | 0.0004 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0004 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0005 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0005 |